Integrative Medicine
Converting Experimental Regeneration
into Staged End-Stage Clinical Pathways
Structured translational framework transforming preclinical regenerative science into bedside pathways.
Who These Pathways Are Designed For
Patient Category 1
Allergology & Immunology
Patient Category 2
Autoimmunology
Patient Category 3
Cardiology
Patient Category 4
Dermatology
Patient Category 5
Endocrinology
Patient Category 6
Gastroenterology
Patient Category 7
Gynecology
Patient Category 8
Haematology
Patient Category 9
Nephrology
Patient Category 10
Neurology
Patient Category 11
Orthopedics
Patient Category 12
Oncology
Clinical Experience & Reported Outcomes
Publicly reported SGP data describes 28,000+ end-stage patients treated. Among those adhering strictly to protocol, more than 63% became medicine-free, with approximately 95% reporting significant quality-of-life improvements. (Sai Ganga Panakeia)
Severe Hypoxic Encephalopathy — Important Note
This program includes staged pathways for profound hypoxic-ischemic brain injury and coma states. Clinical framing follows structured safety screening, ethical oversight, and documented outcome tracking.